|
Nanoco Group PLC - Company Profile Snapshot
| Company Profile: |
Nanoco Group PLC |
| Ticker: |
NANO |
| Exchanges: |
LON |
| 2008 Sales: |
n/a |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Ethical Drug Manufacturers |
| Country: |
UNITED KINGDOM |
| Employees: |
6 |
Business Description
Nanoco Group PLC Formerly known as Evolutec Group PLC. The Group's principal activity is providing research and development of biopharmaceutical products. It develops drugs for allergy, inflammation and autoimmune disease. Products include rEV131, rEV576, rEV598 and anti-tick vaccine. The Group operates in The United Kingdom, Rest of Europe and North America.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
